nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP2D6—Lomustine—brain cancer	0.126	0.282	CbGbCtD
Mefloquine—CYP2D6—Hydroxyurea—brain cancer	0.0952	0.213	CbGbCtD
Mefloquine—CYP3A4—Temozolomide—brain cancer	0.0939	0.211	CbGbCtD
Mefloquine—CYP3A4—Lomustine—brain cancer	0.0799	0.179	CbGbCtD
Mefloquine—ABCB1—Etoposide—brain cancer	0.0322	0.0722	CbGbCtD
Mefloquine—CYP3A4—Etoposide—brain cancer	0.0193	0.0433	CbGbCtD
Mefloquine—Flecainide—CYP2C9—brain cancer	0.0121	1	CrCbGaD
Mefloquine—HBA2—endothelium—brain cancer	0.0114	0.0723	CbGeAlD
Mefloquine—HBA1—hindbrain—brain cancer	0.0109	0.0692	CbGeAlD
Mefloquine—HBA2—blood vessel—brain cancer	0.0105	0.0666	CbGeAlD
Mefloquine—ADORA2A—ganglion—brain cancer	0.00686	0.0436	CbGeAlD
Mefloquine—HBA1—brainstem—brain cancer	0.00624	0.0397	CbGeAlD
Mefloquine—ADORA1—ganglion—brain cancer	0.00592	0.0377	CbGeAlD
Mefloquine—HBA1—telencephalon—brain cancer	0.00553	0.0352	CbGeAlD
Mefloquine—HBA1—spinal cord—brain cancer	0.00388	0.0247	CbGeAlD
Mefloquine—HBA2—spinal cord—brain cancer	0.00356	0.0227	CbGeAlD
Mefloquine—HBA1—endocrine gland—brain cancer	0.00349	0.0222	CbGeAlD
Mefloquine—HBA1—head—brain cancer	0.00345	0.0219	CbGeAlD
Mefloquine—HBA2—endocrine gland—brain cancer	0.00321	0.0204	CbGeAlD
Mefloquine—HBA2—head—brain cancer	0.00316	0.0201	CbGeAlD
Mefloquine—HBA1—central nervous system—brain cancer	0.00315	0.02	CbGeAlD
Mefloquine—HBA1—cerebellum—brain cancer	0.00307	0.0196	CbGeAlD
Mefloquine—HBA2—central nervous system—brain cancer	0.00289	0.0184	CbGeAlD
Mefloquine—HBA2—cerebellum—brain cancer	0.00282	0.018	CbGeAlD
Mefloquine—ADORA2A—telencephalon—brain cancer	0.00265	0.0168	CbGeAlD
Mefloquine—HBA1—brain—brain cancer	0.0025	0.0159	CbGeAlD
Mefloquine—HBA2—brain—brain cancer	0.00229	0.0146	CbGeAlD
Mefloquine—ADORA1—telencephalon—brain cancer	0.00228	0.0145	CbGeAlD
Mefloquine—ACHE—telencephalon—brain cancer	0.00227	0.0144	CbGeAlD
Mefloquine—ADORA2A—gonad—brain cancer	0.00221	0.014	CbGeAlD
Mefloquine—ADORA2A—spinal cord—brain cancer	0.00185	0.0118	CbGeAlD
Mefloquine—ADORA1—medulla oblongata—brain cancer	0.00179	0.0114	CbGeAlD
Mefloquine—ACHE—medulla oblongata—brain cancer	0.00178	0.0113	CbGeAlD
Mefloquine—ADORA2A—endocrine gland—brain cancer	0.00167	0.0106	CbGeAlD
Mefloquine—ADORA2A—head—brain cancer	0.00165	0.0105	CbGeAlD
Mefloquine—ADORA1—midbrain—brain cancer	0.00164	0.0104	CbGeAlD
Mefloquine—ACHE—midbrain—brain cancer	0.00163	0.0104	CbGeAlD
Mefloquine—ADORA1—spinal cord—brain cancer	0.0016	0.0102	CbGeAlD
Mefloquine—ACHE—spinal cord—brain cancer	0.00159	0.0101	CbGeAlD
Mefloquine—ADORA2A—central nervous system—brain cancer	0.0015	0.00957	CbGeAlD
Mefloquine—ADORA2A—cerebellum—brain cancer	0.00147	0.00935	CbGeAlD
Mefloquine—CYP2D6—hindbrain—brain cancer	0.00145	0.00924	CbGeAlD
Mefloquine—ADORA1—endocrine gland—brain cancer	0.00144	0.00917	CbGeAlD
Mefloquine—ADORA1—head—brain cancer	0.00142	0.00905	CbGeAlD
Mefloquine—ADORA1—central nervous system—brain cancer	0.0013	0.00826	CbGeAlD
Mefloquine—CYP19A1—gonad—brain cancer	0.00129	0.00822	CbGeAlD
Mefloquine—ADORA1—cerebellum—brain cancer	0.00127	0.00807	CbGeAlD
Mefloquine—ACHE—cerebellum—brain cancer	0.00126	0.00802	CbGeAlD
Mefloquine—BCHE—brainstem—brain cancer	0.00126	0.008	CbGeAlD
Mefloquine—ADORA2A—brain—brain cancer	0.00119	0.00759	CbGeAlD
Mefloquine—Hepatic failure—Temozolomide—brain cancer	0.00116	0.00464	CcSEcCtD
Mefloquine—BCHE—telencephalon—brain cancer	0.00112	0.0071	CbGeAlD
Mefloquine—Flushing—Procarbazine—brain cancer	0.00111	0.00442	CcSEcCtD
Mefloquine—ABCB1—blood vessel—brain cancer	0.0011	0.00697	CbGeAlD
Mefloquine—Neuropathy—Etoposide—brain cancer	0.00108	0.00431	CcSEcCtD
Mefloquine—Chills—Procarbazine—brain cancer	0.00107	0.00428	CcSEcCtD
Mefloquine—Body temperature increased—Lomustine—brain cancer	0.00106	0.00422	CcSEcCtD
Mefloquine—Alopecia—Procarbazine—brain cancer	0.00105	0.00421	CcSEcCtD
Mefloquine—ADORA1—brain—brain cancer	0.00103	0.00656	CbGeAlD
Mefloquine—Affect lability—Temozolomide—brain cancer	0.00103	0.0041	CcSEcCtD
Mefloquine—ACHE—brain—brain cancer	0.00102	0.00652	CbGeAlD
Mefloquine—Ataxia—Carmustine—brain cancer	0.00102	0.00405	CcSEcCtD
Mefloquine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00101	0.00403	CcSEcCtD
Mefloquine—Mood swings—Temozolomide—brain cancer	0.000988	0.00395	CcSEcCtD
Mefloquine—Ataxia—Temozolomide—brain cancer	0.000981	0.00392	CcSEcCtD
Mefloquine—CYP19A1—endocrine gland—brain cancer	0.000977	0.00622	CbGeAlD
Mefloquine—Tremor—Procarbazine—brain cancer	0.000973	0.00389	CcSEcCtD
Mefloquine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000973	0.00389	CcSEcCtD
Mefloquine—CYP19A1—head—brain cancer	0.000964	0.00614	CbGeAlD
Mefloquine—Muscular weakness—Carmustine—brain cancer	0.000952	0.0038	CcSEcCtD
Mefloquine—Syncope—Procarbazine—brain cancer	0.000932	0.00372	CcSEcCtD
Mefloquine—Leukopenia—Procarbazine—brain cancer	0.00093	0.00371	CcSEcCtD
Mefloquine—Muscular weakness—Temozolomide—brain cancer	0.00092	0.00367	CcSEcCtD
Mefloquine—Hallucination—Hydroxyurea—brain cancer	0.000919	0.00367	CcSEcCtD
Mefloquine—Loss of consciousness—Procarbazine—brain cancer	0.000913	0.00365	CcSEcCtD
Mefloquine—BCHE—pituitary gland—brain cancer	0.000908	0.00578	CbGeAlD
Mefloquine—Convulsion—Procarbazine—brain cancer	0.0009	0.0036	CcSEcCtD
Mefloquine—Hypertension—Procarbazine—brain cancer	0.000897	0.00358	CcSEcCtD
Mefloquine—Myalgia—Procarbazine—brain cancer	0.000885	0.00353	CcSEcCtD
Mefloquine—Arthralgia—Procarbazine—brain cancer	0.000885	0.00353	CcSEcCtD
Mefloquine—Anxiety—Procarbazine—brain cancer	0.000882	0.00352	CcSEcCtD
Mefloquine—CYP19A1—central nervous system—brain cancer	0.00088	0.0056	CbGeAlD
Mefloquine—BCHE—medulla oblongata—brain cancer	0.000876	0.00558	CbGeAlD
Mefloquine—Confusional state—Procarbazine—brain cancer	0.000855	0.00342	CcSEcCtD
Mefloquine—Vomiting—Lomustine—brain cancer	0.000849	0.00339	CcSEcCtD
Mefloquine—Oedema—Procarbazine—brain cancer	0.000848	0.00339	CcSEcCtD
Mefloquine—Angiopathy—Hydroxyurea—brain cancer	0.000838	0.00335	CcSEcCtD
Mefloquine—Pneumonia—Carmustine—brain cancer	0.000837	0.00334	CcSEcCtD
Mefloquine—Shock—Procarbazine—brain cancer	0.000834	0.00333	CcSEcCtD
Mefloquine—CYP2D6—brainstem—brain cancer	0.000833	0.0053	CbGeAlD
Mefloquine—Thrombocytopenia—Procarbazine—brain cancer	0.00083	0.00332	CcSEcCtD
Mefloquine—Chills—Hydroxyurea—brain cancer	0.000829	0.00331	CcSEcCtD
Mefloquine—Tachycardia—Procarbazine—brain cancer	0.000828	0.00331	CcSEcCtD
Mefloquine—Hyperhidrosis—Procarbazine—brain cancer	0.00082	0.00327	CcSEcCtD
Mefloquine—Renal failure—Carmustine—brain cancer	0.000818	0.00327	CcSEcCtD
Mefloquine—Alopecia—Hydroxyurea—brain cancer	0.000816	0.00326	CcSEcCtD
Mefloquine—Neuropathy peripheral—Carmustine—brain cancer	0.000815	0.00326	CcSEcCtD
Mefloquine—Pneumonia—Temozolomide—brain cancer	0.000809	0.00323	CcSEcCtD
Mefloquine—Erythema—Hydroxyurea—brain cancer	0.000804	0.00321	CcSEcCtD
Mefloquine—BCHE—midbrain—brain cancer	0.000801	0.0051	CbGeAlD
Mefloquine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000797	0.00318	CcSEcCtD
Mefloquine—Nausea—Lomustine—brain cancer	0.000793	0.00317	CcSEcCtD
Mefloquine—Hypotension—Procarbazine—brain cancer	0.000792	0.00316	CcSEcCtD
Mefloquine—Neuropathy peripheral—Temozolomide—brain cancer	0.000788	0.00315	CcSEcCtD
Mefloquine—BCHE—spinal cord—brain cancer	0.000782	0.00497	CbGeAlD
Mefloquine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000773	0.00309	CcSEcCtD
Mefloquine—Insomnia—Procarbazine—brain cancer	0.000767	0.00306	CcSEcCtD
Mefloquine—Paraesthesia—Procarbazine—brain cancer	0.000761	0.00304	CcSEcCtD
Mefloquine—Hepatobiliary disease—Temozolomide—brain cancer	0.00076	0.00304	CcSEcCtD
Mefloquine—Somnolence—Procarbazine—brain cancer	0.000754	0.00301	CcSEcCtD
Mefloquine—Cramp muscle—Etoposide—brain cancer	0.000752	0.003	CcSEcCtD
Mefloquine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000746	0.00298	CcSEcCtD
Mefloquine—Hallucination—Carmustine—brain cancer	0.000743	0.00297	CcSEcCtD
Mefloquine—CYP2D6—telencephalon—brain cancer	0.000739	0.0047	CbGeAlD
Mefloquine—Decreased appetite—Procarbazine—brain cancer	0.000737	0.00294	CcSEcCtD
Mefloquine—Connective tissue disorder—Carmustine—brain cancer	0.000734	0.00293	CcSEcCtD
Mefloquine—Fatigue—Procarbazine—brain cancer	0.000731	0.00292	CcSEcCtD
Mefloquine—Malaise—Hydroxyurea—brain cancer	0.000725	0.0029	CcSEcCtD
Mefloquine—Leukopenia—Hydroxyurea—brain cancer	0.00072	0.00287	CcSEcCtD
Mefloquine—Visual impairment—Carmustine—brain cancer	0.00072	0.00287	CcSEcCtD
Mefloquine—Hallucination—Temozolomide—brain cancer	0.000718	0.00287	CcSEcCtD
Mefloquine—Connective tissue disorder—Temozolomide—brain cancer	0.000709	0.00283	CcSEcCtD
Mefloquine—BCHE—endocrine gland—brain cancer	0.000704	0.00448	CbGeAlD
Mefloquine—CYP19A1—brain—brain cancer	0.000699	0.00445	CbGeAlD
Mefloquine—Feeling abnormal—Procarbazine—brain cancer	0.000699	0.00279	CcSEcCtD
Mefloquine—Eye disorder—Carmustine—brain cancer	0.000698	0.00279	CcSEcCtD
Mefloquine—Convulsion—Hydroxyurea—brain cancer	0.000697	0.00278	CcSEcCtD
Mefloquine—Visual impairment—Temozolomide—brain cancer	0.000695	0.00278	CcSEcCtD
Mefloquine—BCHE—head—brain cancer	0.000695	0.00442	CbGeAlD
Mefloquine—Gastrointestinal pain—Procarbazine—brain cancer	0.000693	0.00277	CcSEcCtD
Mefloquine—Flushing—Carmustine—brain cancer	0.000693	0.00277	CcSEcCtD
Mefloquine—Erythema multiforme—Temozolomide—brain cancer	0.000682	0.00273	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00068	0.00272	CcSEcCtD
Mefloquine—Discomfort—Hydroxyurea—brain cancer	0.000676	0.0027	CcSEcCtD
Mefloquine—Eye disorder—Temozolomide—brain cancer	0.000674	0.00269	CcSEcCtD
Mefloquine—Urticaria—Procarbazine—brain cancer	0.000674	0.00269	CcSEcCtD
Mefloquine—Tinnitus—Temozolomide—brain cancer	0.000673	0.00269	CcSEcCtD
Mefloquine—Body temperature increased—Procarbazine—brain cancer	0.00067	0.00268	CcSEcCtD
Mefloquine—Abdominal pain—Procarbazine—brain cancer	0.00067	0.00268	CcSEcCtD
Mefloquine—Flushing—Temozolomide—brain cancer	0.00067	0.00268	CcSEcCtD
Mefloquine—Cardiac disorder—Temozolomide—brain cancer	0.00067	0.00268	CcSEcCtD
Mefloquine—Alopecia—Carmustine—brain cancer	0.00066	0.00264	CcSEcCtD
Mefloquine—Oedema—Hydroxyurea—brain cancer	0.000656	0.00262	CcSEcCtD
Mefloquine—Angiopathy—Temozolomide—brain cancer	0.000655	0.00262	CcSEcCtD
Mefloquine—Mental disorder—Carmustine—brain cancer	0.000654	0.00261	CcSEcCtD
Mefloquine—Mediastinal disorder—Temozolomide—brain cancer	0.00065	0.0026	CcSEcCtD
Mefloquine—Malnutrition—Carmustine—brain cancer	0.00065	0.0026	CcSEcCtD
Mefloquine—Erythema—Carmustine—brain cancer	0.00065	0.0026	CcSEcCtD
Mefloquine—Chills—Temozolomide—brain cancer	0.000648	0.00259	CcSEcCtD
Mefloquine—Pneumonia—Etoposide—brain cancer	0.000647	0.00258	CcSEcCtD
Mefloquine—Nervous system disorder—Hydroxyurea—brain cancer	0.000644	0.00257	CcSEcCtD
Mefloquine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000643	0.00257	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000638	0.00255	CcSEcCtD
Mefloquine—Alopecia—Temozolomide—brain cancer	0.000638	0.00255	CcSEcCtD
Mefloquine—Skin disorder—Hydroxyurea—brain cancer	0.000637	0.00255	CcSEcCtD
Mefloquine—BCHE—central nervous system—brain cancer	0.000634	0.00403	CbGeAlD
Mefloquine—Renal failure—Etoposide—brain cancer	0.000632	0.00253	CcSEcCtD
Mefloquine—Mental disorder—Temozolomide—brain cancer	0.000632	0.00253	CcSEcCtD
Mefloquine—Neuropathy peripheral—Etoposide—brain cancer	0.000631	0.00252	CcSEcCtD
Mefloquine—Erythema—Temozolomide—brain cancer	0.000628	0.00251	CcSEcCtD
Mefloquine—Malnutrition—Temozolomide—brain cancer	0.000628	0.00251	CcSEcCtD
Mefloquine—Hypersensitivity—Procarbazine—brain cancer	0.000625	0.0025	CcSEcCtD
Mefloquine—BCHE—cerebellum—brain cancer	0.00062	0.00394	CbGeAlD
Mefloquine—Vision blurred—Carmustine—brain cancer	0.000613	0.00245	CcSEcCtD
Mefloquine—Tremor—Carmustine—brain cancer	0.000609	0.00243	CcSEcCtD
Mefloquine—Asthenia—Procarbazine—brain cancer	0.000608	0.00243	CcSEcCtD
Mefloquine—Hepatobiliary disease—Etoposide—brain cancer	0.000608	0.00243	CcSEcCtD
Mefloquine—Agranulocytosis—Etoposide—brain cancer	0.0006	0.0024	CcSEcCtD
Mefloquine—Pruritus—Procarbazine—brain cancer	0.0006	0.0024	CcSEcCtD
Mefloquine—Agitation—Carmustine—brain cancer	0.000597	0.00239	CcSEcCtD
Mefloquine—Vision blurred—Temozolomide—brain cancer	0.000592	0.00236	CcSEcCtD
Mefloquine—Tremor—Temozolomide—brain cancer	0.000589	0.00235	CcSEcCtD
Mefloquine—Dyspnoea—Hydroxyurea—brain cancer	0.000585	0.00234	CcSEcCtD
Mefloquine—Somnolence—Hydroxyurea—brain cancer	0.000583	0.00233	CcSEcCtD
Mefloquine—Ill-defined disorder—Temozolomide—brain cancer	0.000583	0.00233	CcSEcCtD
Mefloquine—Leukopenia—Carmustine—brain cancer	0.000582	0.00232	CcSEcCtD
Mefloquine—Diarrhoea—Procarbazine—brain cancer	0.00058	0.00232	CcSEcCtD
Mefloquine—Dyspepsia—Hydroxyurea—brain cancer	0.000578	0.00231	CcSEcCtD
Mefloquine—Agitation—Temozolomide—brain cancer	0.000577	0.00231	CcSEcCtD
Mefloquine—Decreased appetite—Hydroxyurea—brain cancer	0.000571	0.00228	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000567	0.00226	CcSEcCtD
Mefloquine—Malaise—Temozolomide—brain cancer	0.000567	0.00226	CcSEcCtD
Mefloquine—Fatigue—Hydroxyurea—brain cancer	0.000566	0.00226	CcSEcCtD
Mefloquine—Vertigo—Temozolomide—brain cancer	0.000564	0.00225	CcSEcCtD
Mefloquine—Convulsion—Carmustine—brain cancer	0.000563	0.00225	CcSEcCtD
Mefloquine—Leukopenia—Temozolomide—brain cancer	0.000562	0.00225	CcSEcCtD
Mefloquine—Hypertension—Carmustine—brain cancer	0.000561	0.00224	CcSEcCtD
Mefloquine—Dizziness—Procarbazine—brain cancer	0.000561	0.00224	CcSEcCtD
Mefloquine—Palpitations—Temozolomide—brain cancer	0.000555	0.00222	CcSEcCtD
Mefloquine—Myalgia—Carmustine—brain cancer	0.000553	0.00221	CcSEcCtD
Mefloquine—Chest pain—Carmustine—brain cancer	0.000553	0.00221	CcSEcCtD
Mefloquine—Anxiety—Carmustine—brain cancer	0.000552	0.0022	CcSEcCtD
Mefloquine—Erythema multiforme—Etoposide—brain cancer	0.000546	0.00218	CcSEcCtD
Mefloquine—Convulsion—Temozolomide—brain cancer	0.000544	0.00217	CcSEcCtD
Mefloquine—Hypertension—Temozolomide—brain cancer	0.000542	0.00217	CcSEcCtD
Mefloquine—Feeling abnormal—Hydroxyurea—brain cancer	0.000541	0.00216	CcSEcCtD
Mefloquine—Eye disorder—Etoposide—brain cancer	0.00054	0.00216	CcSEcCtD
Mefloquine—Vomiting—Procarbazine—brain cancer	0.000539	0.00215	CcSEcCtD
Mefloquine—Cardiac disorder—Etoposide—brain cancer	0.000536	0.00214	CcSEcCtD
Mefloquine—Flushing—Etoposide—brain cancer	0.000536	0.00214	CcSEcCtD
Mefloquine—Confusional state—Carmustine—brain cancer	0.000535	0.00214	CcSEcCtD
Mefloquine—Myalgia—Temozolomide—brain cancer	0.000535	0.00214	CcSEcCtD
Mefloquine—Arthralgia—Temozolomide—brain cancer	0.000535	0.00214	CcSEcCtD
Mefloquine—Rash—Procarbazine—brain cancer	0.000535	0.00214	CcSEcCtD
Mefloquine—Dermatitis—Procarbazine—brain cancer	0.000534	0.00213	CcSEcCtD
Mefloquine—Anxiety—Temozolomide—brain cancer	0.000533	0.00213	CcSEcCtD
Mefloquine—ABCB1—telencephalon—brain cancer	0.000532	0.00338	CbGeAlD
Mefloquine—Headache—Procarbazine—brain cancer	0.000531	0.00212	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000531	0.00212	CcSEcCtD
Mefloquine—Oedema—Carmustine—brain cancer	0.000531	0.00212	CcSEcCtD
Mefloquine—Discomfort—Temozolomide—brain cancer	0.000528	0.00211	CcSEcCtD
Mefloquine—Angiopathy—Etoposide—brain cancer	0.000524	0.00209	CcSEcCtD
Mefloquine—Mediastinal disorder—Etoposide—brain cancer	0.00052	0.00208	CcSEcCtD
Mefloquine—Thrombocytopenia—Carmustine—brain cancer	0.000519	0.00207	CcSEcCtD
Mefloquine—Body temperature increased—Hydroxyurea—brain cancer	0.000519	0.00207	CcSEcCtD
Mefloquine—Chills—Etoposide—brain cancer	0.000518	0.00207	CcSEcCtD
Mefloquine—Tachycardia—Carmustine—brain cancer	0.000518	0.00207	CcSEcCtD
Mefloquine—Confusional state—Temozolomide—brain cancer	0.000517	0.00206	CcSEcCtD
Mefloquine—Anaphylactic shock—Temozolomide—brain cancer	0.000513	0.00205	CcSEcCtD
Mefloquine—Oedema—Temozolomide—brain cancer	0.000513	0.00205	CcSEcCtD
Mefloquine—Alopecia—Etoposide—brain cancer	0.00051	0.00204	CcSEcCtD
Mefloquine—Nausea—Procarbazine—brain cancer	0.000504	0.00201	CcSEcCtD
Mefloquine—BCHE—brain—brain cancer	0.000503	0.0032	CbGeAlD
Mefloquine—Nervous system disorder—Temozolomide—brain cancer	0.000503	0.00201	CcSEcCtD
Mefloquine—Thrombocytopenia—Temozolomide—brain cancer	0.000502	0.00201	CcSEcCtD
Mefloquine—Skin disorder—Temozolomide—brain cancer	0.000498	0.00199	CcSEcCtD
Mefloquine—Hypotension—Carmustine—brain cancer	0.000496	0.00198	CcSEcCtD
Mefloquine—Hyperhidrosis—Temozolomide—brain cancer	0.000496	0.00198	CcSEcCtD
Mefloquine—Hypersensitivity—Hydroxyurea—brain cancer	0.000484	0.00193	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000483	0.00193	CcSEcCtD
Mefloquine—Muscle spasms—Etoposide—brain cancer	0.000483	0.00193	CcSEcCtD
Mefloquine—Insomnia—Carmustine—brain cancer	0.00048	0.00192	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—OR4C12—brain cancer	0.00048	0.00357	CbGpPWpGaD
Mefloquine—Paraesthesia—Carmustine—brain cancer	0.000476	0.0019	CcSEcCtD
Mefloquine—CYP3A4—endocrine gland—brain cancer	0.000474	0.00301	CbGeAlD
Mefloquine—Dyspnoea—Carmustine—brain cancer	0.000473	0.00189	CcSEcCtD
Mefloquine—Somnolence—Carmustine—brain cancer	0.000472	0.00188	CcSEcCtD
Mefloquine—Asthenia—Hydroxyurea—brain cancer	0.000471	0.00188	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—ABR—brain cancer	0.000468	0.00348	CbGpPWpGaD
Mefloquine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000467	0.00187	CcSEcCtD
Mefloquine—Ill-defined disorder—Etoposide—brain cancer	0.000466	0.00186	CcSEcCtD
Mefloquine—CYP2D6—endocrine gland—brain cancer	0.000466	0.00297	CbGeAlD
Mefloquine—Insomnia—Temozolomide—brain cancer	0.000464	0.00185	CcSEcCtD
Mefloquine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000463	0.00344	CbGpPWpGaD
Mefloquine—Decreased appetite—Carmustine—brain cancer	0.000461	0.00184	CcSEcCtD
Mefloquine—HBA1—Metabolism—BSG—brain cancer	0.000461	0.00343	CbGpPWpGaD
Mefloquine—Paraesthesia—Temozolomide—brain cancer	0.00046	0.00184	CcSEcCtD
Mefloquine—CYP2D6—head—brain cancer	0.00046	0.00293	CbGeAlD
Mefloquine—Gastrointestinal disorder—Carmustine—brain cancer	0.000458	0.00183	CcSEcCtD
Mefloquine—Dyspnoea—Temozolomide—brain cancer	0.000457	0.00183	CcSEcCtD
Mefloquine—Somnolence—Temozolomide—brain cancer	0.000456	0.00182	CcSEcCtD
Mefloquine—Malaise—Etoposide—brain cancer	0.000453	0.00181	CcSEcCtD
Mefloquine—Vertigo—Etoposide—brain cancer	0.000452	0.0018	CcSEcCtD
Mefloquine—Dyspepsia—Temozolomide—brain cancer	0.000451	0.0018	CcSEcCtD
Mefloquine—Leukopenia—Etoposide—brain cancer	0.00045	0.0018	CcSEcCtD
Mefloquine—Diarrhoea—Hydroxyurea—brain cancer	0.000449	0.00179	CcSEcCtD
Mefloquine—Decreased appetite—Temozolomide—brain cancer	0.000446	0.00178	CcSEcCtD
Mefloquine—ABCB1—gonad—brain cancer	0.000444	0.00282	CbGeAlD
Mefloquine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000443	0.00177	CcSEcCtD
Mefloquine—Fatigue—Temozolomide—brain cancer	0.000442	0.00177	CcSEcCtD
Mefloquine—Loss of consciousness—Etoposide—brain cancer	0.000442	0.00176	CcSEcCtD
Mefloquine—Feeling abnormal—Carmustine—brain cancer	0.000437	0.00175	CcSEcCtD
Mefloquine—Convulsion—Etoposide—brain cancer	0.000436	0.00174	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—OR14C36—brain cancer	0.000436	0.00324	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—OR4C12—brain cancer	0.000436	0.00324	CbGpPWpGaD
Mefloquine—Hypertension—Etoposide—brain cancer	0.000434	0.00173	CcSEcCtD
Mefloquine—Dizziness—Hydroxyurea—brain cancer	0.000434	0.00173	CcSEcCtD
Mefloquine—Gastrointestinal pain—Carmustine—brain cancer	0.000434	0.00173	CcSEcCtD
Mefloquine—ABCB1—pituitary gland—brain cancer	0.000433	0.00275	CbGeAlD
Mefloquine—Chest pain—Etoposide—brain cancer	0.000428	0.00171	CcSEcCtD
Mefloquine—CYP3A4—central nervous system—brain cancer	0.000427	0.00272	CbGeAlD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000425	0.0017	CcSEcCtD
Mefloquine—Discomfort—Etoposide—brain cancer	0.000423	0.00169	CcSEcCtD
Mefloquine—Feeling abnormal—Temozolomide—brain cancer	0.000422	0.00169	CcSEcCtD
Mefloquine—ACHE—ATF-2 transcription factor network—CDK4—brain cancer	0.000422	0.00314	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—PTCH2—brain cancer	0.000422	0.00314	CbGpPWpGaD
Mefloquine—CYP2D6—central nervous system—brain cancer	0.00042	0.00267	CbGeAlD
Mefloquine—Abdominal pain—Carmustine—brain cancer	0.000419	0.00168	CcSEcCtD
Mefloquine—Body temperature increased—Carmustine—brain cancer	0.000419	0.00168	CcSEcCtD
Mefloquine—Gastrointestinal pain—Temozolomide—brain cancer	0.000419	0.00167	CcSEcCtD
Mefloquine—ABCB1—medulla oblongata—brain cancer	0.000418	0.00266	CbGeAlD
Mefloquine—Vomiting—Hydroxyurea—brain cancer	0.000417	0.00167	CcSEcCtD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000415	0.00309	CbGpPWpGaD
Mefloquine—Rash—Hydroxyurea—brain cancer	0.000414	0.00165	CcSEcCtD
Mefloquine—Confusional state—Etoposide—brain cancer	0.000414	0.00165	CcSEcCtD
Mefloquine—HBA2—Metabolism—ENO2—brain cancer	0.000414	0.00308	CbGpPWpGaD
Mefloquine—Dermatitis—Hydroxyurea—brain cancer	0.000413	0.00165	CcSEcCtD
Mefloquine—Headache—Hydroxyurea—brain cancer	0.000411	0.00164	CcSEcCtD
Mefloquine—CYP2D6—cerebellum—brain cancer	0.000411	0.00261	CbGeAlD
Mefloquine—Anaphylactic shock—Etoposide—brain cancer	0.00041	0.00164	CcSEcCtD
Mefloquine—Urticaria—Temozolomide—brain cancer	0.000407	0.00163	CcSEcCtD
Mefloquine—Body temperature increased—Temozolomide—brain cancer	0.000405	0.00162	CcSEcCtD
Mefloquine—Abdominal pain—Temozolomide—brain cancer	0.000405	0.00162	CcSEcCtD
Mefloquine—Thrombocytopenia—Etoposide—brain cancer	0.000402	0.0016	CcSEcCtD
Mefloquine—Tachycardia—Etoposide—brain cancer	0.0004	0.0016	CcSEcCtD
Mefloquine—Skin disorder—Etoposide—brain cancer	0.000399	0.00159	CcSEcCtD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000397	0.00295	CbGpPWpGaD
Mefloquine—Hyperhidrosis—Etoposide—brain cancer	0.000397	0.00158	CcSEcCtD
Mefloquine—HBA1—Metabolism—IDH1—brain cancer	0.000397	0.00295	CbGpPWpGaD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000392	0.00291	CbGpPWpGaD
Mefloquine—Hypersensitivity—Carmustine—brain cancer	0.000391	0.00156	CcSEcCtD
Mefloquine—Nausea—Hydroxyurea—brain cancer	0.00039	0.00156	CcSEcCtD
Mefloquine—Hypotension—Etoposide—brain cancer	0.000383	0.00153	CcSEcCtD
Mefloquine—ABCB1—midbrain—brain cancer	0.000382	0.00243	CbGeAlD
Mefloquine—Asthenia—Carmustine—brain cancer	0.000381	0.00152	CcSEcCtD
Mefloquine—Hypersensitivity—Temozolomide—brain cancer	0.000378	0.00151	CcSEcCtD
Mefloquine—ABCB1—spinal cord—brain cancer	0.000372	0.00237	CbGeAlD
Mefloquine—ADORA2A—GPCR downstream signaling—OR4C12—brain cancer	0.00037	0.00276	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—OR14C36—brain cancer	0.00037	0.00276	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.00037	0.00275	CbGpPWpGaD
Mefloquine—Paraesthesia—Etoposide—brain cancer	0.000368	0.00147	CcSEcCtD
Mefloquine—Asthenia—Temozolomide—brain cancer	0.000368	0.00147	CcSEcCtD
Mefloquine—Dyspnoea—Etoposide—brain cancer	0.000366	0.00146	CcSEcCtD
Mefloquine—Somnolence—Etoposide—brain cancer	0.000365	0.00146	CcSEcCtD
Mefloquine—Diarrhoea—Carmustine—brain cancer	0.000363	0.00145	CcSEcCtD
Mefloquine—Pruritus—Temozolomide—brain cancer	0.000363	0.00145	CcSEcCtD
Mefloquine—Decreased appetite—Etoposide—brain cancer	0.000357	0.00142	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Etoposide—brain cancer	0.000354	0.00141	CcSEcCtD
Mefloquine—Fatigue—Etoposide—brain cancer	0.000354	0.00141	CcSEcCtD
Mefloquine—Dizziness—Carmustine—brain cancer	0.000351	0.0014	CcSEcCtD
Mefloquine—Diarrhoea—Temozolomide—brain cancer	0.000351	0.0014	CcSEcCtD
Mefloquine—ADORA1—Circadian rythm related genes—SIRT1—brain cancer	0.00034	0.00253	CbGpPWpGaD
Mefloquine—Dizziness—Temozolomide—brain cancer	0.000339	0.00135	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000339	0.00252	CbGpPWpGaD
Mefloquine—Feeling abnormal—Etoposide—brain cancer	0.000338	0.00135	CcSEcCtD
Mefloquine—Vomiting—Carmustine—brain cancer	0.000337	0.00135	CcSEcCtD
Mefloquine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000337	0.00251	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—OR4C12—brain cancer	0.000336	0.0025	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—OR14C36—brain cancer	0.000336	0.0025	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Etoposide—brain cancer	0.000335	0.00134	CcSEcCtD
Mefloquine—ABCB1—endocrine gland—brain cancer	0.000335	0.00213	CbGeAlD
Mefloquine—Rash—Carmustine—brain cancer	0.000335	0.00134	CcSEcCtD
Mefloquine—Dermatitis—Carmustine—brain cancer	0.000334	0.00133	CcSEcCtD
Mefloquine—CYP2D6—brain—brain cancer	0.000333	0.00212	CbGeAlD
Mefloquine—Headache—Carmustine—brain cancer	0.000332	0.00133	CcSEcCtD
Mefloquine—ABCB1—head—brain cancer	0.000331	0.00211	CbGeAlD
Mefloquine—Vomiting—Temozolomide—brain cancer	0.000326	0.0013	CcSEcCtD
Mefloquine—Urticaria—Etoposide—brain cancer	0.000326	0.0013	CcSEcCtD
Mefloquine—Body temperature increased—Etoposide—brain cancer	0.000324	0.0013	CcSEcCtD
Mefloquine—Abdominal pain—Etoposide—brain cancer	0.000324	0.0013	CcSEcCtD
Mefloquine—Rash—Temozolomide—brain cancer	0.000323	0.00129	CcSEcCtD
Mefloquine—Dermatitis—Temozolomide—brain cancer	0.000323	0.00129	CcSEcCtD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000322	0.00239	CbGpPWpGaD
Mefloquine—Headache—Temozolomide—brain cancer	0.000321	0.00128	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000321	0.00239	CbGpPWpGaD
Mefloquine—Nausea—Carmustine—brain cancer	0.000315	0.00126	CcSEcCtD
Mefloquine—HBA1—Metabolism—ENO2—brain cancer	0.000313	0.00233	CbGpPWpGaD
Mefloquine—Nausea—Temozolomide—brain cancer	0.000305	0.00122	CcSEcCtD
Mefloquine—Hypersensitivity—Etoposide—brain cancer	0.000302	0.00121	CcSEcCtD
Mefloquine—ABCB1—central nervous system—brain cancer	0.000302	0.00192	CbGeAlD
Mefloquine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000299	0.00222	CbGpPWpGaD
Mefloquine—ABCB1—cerebellum—brain cancer	0.000295	0.00188	CbGeAlD
Mefloquine—Asthenia—Etoposide—brain cancer	0.000294	0.00118	CcSEcCtD
Mefloquine—Pruritus—Etoposide—brain cancer	0.00029	0.00116	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—VAV1—brain cancer	0.000288	0.00215	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—SHH—brain cancer	0.000282	0.0021	CbGpPWpGaD
Mefloquine—Diarrhoea—Etoposide—brain cancer	0.000281	0.00112	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—PTCH2—brain cancer	0.000281	0.00209	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—CCND1—brain cancer	0.000273	0.00203	CbGpPWpGaD
Mefloquine—Dizziness—Etoposide—brain cancer	0.000271	0.00108	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000271	0.00202	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—SMO—brain cancer	0.000267	0.00199	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—PTCH1—brain cancer	0.000267	0.00199	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—SIRT1—brain cancer	0.000262	0.00195	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000261	0.00195	CbGpPWpGaD
Mefloquine—Vomiting—Etoposide—brain cancer	0.000261	0.00104	CcSEcCtD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000259	0.00193	CbGpPWpGaD
Mefloquine—Rash—Etoposide—brain cancer	0.000259	0.00103	CcSEcCtD
Mefloquine—Dermatitis—Etoposide—brain cancer	0.000258	0.00103	CcSEcCtD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000258	0.00192	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—OR4C12—brain cancer	0.000257	0.00191	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—OR14C36—brain cancer	0.000257	0.00191	CbGpPWpGaD
Mefloquine—Headache—Etoposide—brain cancer	0.000257	0.00103	CcSEcCtD
Mefloquine—ADORA1—Circadian rythm related genes—CDK4—brain cancer	0.000257	0.00191	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000247	0.00184	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000245	0.00182	CbGpPWpGaD
Mefloquine—Nausea—Etoposide—brain cancer	0.000244	0.000973	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—ABR—brain cancer	0.000243	0.00181	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000242	0.0018	CbGpPWpGaD
Mefloquine—ABCB1—brain—brain cancer	0.00024	0.00153	CbGeAlD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFRA—brain cancer	0.000236	0.00176	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000225	0.00167	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000223	0.00166	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—VAV1—brain cancer	0.000222	0.00165	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—ABR—brain cancer	0.00022	0.00164	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DTX2—brain cancer	0.000219	0.00163	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000218	0.00162	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000218	0.00162	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—SHH—brain cancer	0.000218	0.00162	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTCH2—brain cancer	0.000217	0.00161	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000216	0.0016	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS2—brain cancer	0.000207	0.00154	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—SMO—brain cancer	0.000206	0.00153	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—PTCH1—brain cancer	0.000206	0.00153	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—CTNNB1—brain cancer	0.000202	0.0015	CbGpPWpGaD
Mefloquine—ACHE—Phospholipid metabolism—PIK3CG—brain cancer	0.000202	0.0015	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.0002	0.00149	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—OR4C12—brain cancer	0.000199	0.00148	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—OR14C36—brain cancer	0.000199	0.00148	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—CDK4—brain cancer	0.000198	0.00148	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000191	0.00142	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PIK3CG—brain cancer	0.00019	0.00141	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—ABR—brain cancer	0.000187	0.00139	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000183	0.00136	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—PDGFRA—brain cancer	0.000182	0.00135	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—CTNNB1—brain cancer	0.00018	0.00134	CbGpPWpGaD
Mefloquine—BCHE—Phospholipid metabolism—PIK3CG—brain cancer	0.00018	0.00134	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000179	0.00133	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000177	0.00132	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000171	0.00127	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—ABR—brain cancer	0.00017	0.00127	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DTX2—brain cancer	0.000169	0.00126	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000169	0.00125	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTCH2—brain cancer	0.000166	0.00123	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000165	0.00123	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000164	0.00122	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HES5—brain cancer	0.000161	0.0012	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00016	0.00119	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IRS2—brain cancer	0.000159	0.00119	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STRADA—brain cancer	0.000156	0.00116	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000155	0.00116	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TRPC6—brain cancer	0.000154	0.00114	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000147	0.0011	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—SHH—brain cancer	0.000145	0.00108	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PIK3CG—brain cancer	0.000144	0.00107	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000142	0.00106	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00014	0.00104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TRPC6—brain cancer	0.000139	0.00104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—SMO—brain cancer	0.000137	0.00102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PTCH1—brain cancer	0.000137	0.00102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ABR—brain cancer	0.00013	0.000968	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTCH2—brain cancer	0.000128	0.000953	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GLI2—brain cancer	0.000126	0.000935	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HES5—brain cancer	0.000124	0.000923	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000122	0.00091	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000121	0.000898	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STRADA—brain cancer	0.00012	0.000896	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TRPC6—brain cancer	0.000119	0.000882	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000118	0.00088	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GLI1—brain cancer	0.000118	0.000879	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000118	0.000878	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000117	0.000871	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—VAV1—brain cancer	0.000115	0.000856	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SUFU—brain cancer	0.000112	0.000834	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—SHH—brain cancer	0.000112	0.000831	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000111	0.000822	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—RELA—brain cancer	0.00011	0.000819	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—ERBB2—brain cancer	0.000109	0.000814	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—brain cancer	0.000109	0.000814	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP2C9—brain cancer	0.000109	0.000811	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000108	0.000807	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GFAP—brain cancer	0.000108	0.000804	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TRPC6—brain cancer	0.000108	0.000801	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000107	0.000793	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—SMO—brain cancer	0.000106	0.000788	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTCH1—brain cancer	0.000106	0.000788	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000106	0.000786	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—VAV1—brain cancer	0.000104	0.000777	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000103	0.000767	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HEY1—brain cancer	0.000102	0.000762	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ABR—brain cancer	0.0001	0.000748	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DLL1—brain cancer	0.0001	0.000748	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP2C9—brain cancer	0.0001	0.000745	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	9.86e-05	0.000734	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP2C9—brain cancer	9.72e-05	0.000724	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GLI2—brain cancer	9.7e-05	0.000722	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.69e-05	0.000721	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2—brain cancer	9.64e-05	0.000718	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.5e-05	0.000707	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	9.48e-05	0.000706	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	9.46e-05	0.000704	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.38e-05	0.000698	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.29e-05	0.000692	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	9.27e-05	0.00069	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—BSG—brain cancer	9.27e-05	0.00069	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GLI1—brain cancer	9.12e-05	0.000679	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—VAV1—brain cancer	8.88e-05	0.000661	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.72e-05	0.000649	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SUFU—brain cancer	8.65e-05	0.000644	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.55e-05	0.000636	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SHH—brain cancer	8.54e-05	0.000636	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—BSG—brain cancer	8.52e-05	0.000634	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—brain cancer	8.44e-05	0.000628	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.36e-05	0.000622	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GFAP—brain cancer	8.34e-05	0.000621	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—STAT3—brain cancer	8.34e-05	0.000621	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.31e-05	0.000619	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—BSG—brain cancer	8.27e-05	0.000615	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TRPC6—brain cancer	8.24e-05	0.000613	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—VEGFA—brain cancer	8.2e-05	0.00061	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTCH1—brain cancer	8.1e-05	0.000603	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SMO—brain cancer	8.1e-05	0.000603	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—VAV1—brain cancer	8.06e-05	0.0006	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—IDH1—brain cancer	7.97e-05	0.000593	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HEY1—brain cancer	7.91e-05	0.000589	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	7.79e-05	0.00058	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DLL1—brain cancer	7.76e-05	0.000577	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—EGFR—brain cancer	7.58e-05	0.000564	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—IDH1—brain cancer	7.32e-05	0.000545	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PIK3CG—brain cancer	7.3e-05	0.000544	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.18e-05	0.000535	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—IDH1—brain cancer	7.11e-05	0.000529	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.02e-05	0.000523	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.76e-05	0.000503	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CG—brain cancer	6.63e-05	0.000494	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SHH—brain cancer	6.59e-05	0.000491	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.49e-05	0.000483	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOTCH2—brain cancer	6.47e-05	0.000482	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TRPC6—brain cancer	6.36e-05	0.000473	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ENO2—brain cancer	6.3e-05	0.000469	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTCH1—brain cancer	6.25e-05	0.000465	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SMO—brain cancer	6.25e-05	0.000465	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VAV1—brain cancer	6.17e-05	0.000459	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.96e-05	0.000444	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ENO2—brain cancer	5.79e-05	0.000431	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.79e-05	0.000431	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.64e-05	0.00042	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CG—brain cancer	5.64e-05	0.00042	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ENO2—brain cancer	5.62e-05	0.000418	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HES1—brain cancer	5.31e-05	0.000395	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.25e-05	0.000391	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2—brain cancer	5.14e-05	0.000383	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CG—brain cancer	5.12e-05	0.000381	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PDGFRA—brain cancer	5.05e-05	0.000376	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH2—brain cancer	5e-05	0.000372	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SPP1—brain cancer	4.91e-05	0.000365	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VAV1—brain cancer	4.76e-05	0.000355	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2C9—brain cancer	4.74e-05	0.000353	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—brain cancer	4.67e-05	0.000347	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.64e-05	0.000345	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.59e-05	0.000342	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2C9—brain cancer	4.47e-05	0.000333	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IRS2—brain cancer	4.44e-05	0.00033	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HES1—brain cancer	4.1e-05	0.000305	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.04e-05	0.000301	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BSG—brain cancer	4.03e-05	0.0003	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—brain cancer	3.97e-05	0.000295	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CG—brain cancer	3.92e-05	0.000292	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APC—brain cancer	3.92e-05	0.000292	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDGFRA—brain cancer	3.9e-05	0.00029	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CTNNB1—brain cancer	3.81e-05	0.000283	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BSG—brain cancer	3.8e-05	0.000283	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—brain cancer	3.79e-05	0.000282	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.72e-05	0.000277	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.64e-05	0.000271	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—brain cancer	3.6e-05	0.000268	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EGFR—brain cancer	3.57e-05	0.000266	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—IDH1—brain cancer	3.47e-05	0.000258	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IRS2—brain cancer	3.43e-05	0.000255	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CTNNB1—brain cancer	3.4e-05	0.000253	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—IDH1—brain cancer	3.27e-05	0.000243	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RELA—brain cancer	3.06e-05	0.000228	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.06e-05	0.000227	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ERBB2—brain cancer	3.04e-05	0.000226	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CG—brain cancer	3.03e-05	0.000225	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APC—brain cancer	3.03e-05	0.000225	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2C9—brain cancer	2.92e-05	0.000218	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CG—brain cancer	2.89e-05	0.000215	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—brain cancer	2.76e-05	0.000205	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—brain cancer	2.76e-05	0.000205	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ENO2—brain cancer	2.74e-05	0.000204	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCND1—brain cancer	2.69e-05	0.0002	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CTNNB1—brain cancer	2.66e-05	0.000198	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CG—brain cancer	2.66e-05	0.000198	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ENO2—brain cancer	2.58e-05	0.000192	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CG—brain cancer	2.58e-05	0.000192	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BSG—brain cancer	2.48e-05	0.000185	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RELA—brain cancer	2.36e-05	0.000176	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ERBB2—brain cancer	2.35e-05	0.000175	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—brain cancer	2.34e-05	0.000174	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT3—brain cancer	2.32e-05	0.000173	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—brain cancer	2.16e-05	0.00016	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—IDH1—brain cancer	2.14e-05	0.000159	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—brain cancer	2.13e-05	0.000158	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—brain cancer	2.11e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCND1—brain cancer	2.08e-05	0.000154	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CTNNB1—brain cancer	2.06e-05	0.000153	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—brain cancer	1.81e-05	0.000135	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT3—brain cancer	1.79e-05	0.000133	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—brain cancer	1.77e-05	0.000132	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ENO2—brain cancer	1.69e-05	0.000126	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—brain cancer	1.66e-05	0.000124	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—brain cancer	1.63e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—brain cancer	1.37e-05	0.000102	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CG—brain cancer	1.26e-05	9.36e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.19e-05	8.82e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CG—brain cancer	7.75e-06	5.77e-05	CbGpPWpGaD
